Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Pfizer/BioNTech vaccine starts working 10 days after first dose, says FDA | Financial Times
Pfizer-BioNTech COVID-19 vaccine shows real-world efficacy, despite the circulation of B.1.1.7 variant
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose
Those Who Had COVID-19 May Only Need One Dose of Vaccine | Penn Medicine
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
Pfizer vaccine may offer strong protection after first dose, Israeli study finds
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Covid vaccines slash risk of infection, illness and death, UK studies find | Financial Times
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021 | MMWR
Pfizer Covid vaccine is 95% effective, plans to submit to FDA in days
Evaluation of COVID-19 vaccination strategies with a delayed second dose | PLOS Biology
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Are coronavirus vaccines effective against variants? | NHK WORLD-JAPAN News
Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK - BBC News
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
Who Didn't Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines | KFF
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Pfizer-BioNTech COVID-19 vaccine shows real-world efficacy, despite the circulation of B.1.1.7 variant
Changing the UK COVID-19 vaccine dosing schedule - POST
